Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Zura Bio Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 69 | +5 |
| Shares | 35.3M | 1.68K | 41.4M | +6.08M (+17.2%) |
| Value | $37.1M | $1.76K | $179.2M | +$142.2M (+383.4%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Zura Bio Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 3,045,444 | $13.2M | 0.02% |
| Ikarian Capital, LLC | 2,132,322 | $9.23M | 2.09% |
| Boothbay Fund Management, LLC | 824,078 | $3.57M | 0.09% |
| Silverarc Capital Management, LLC | 720,452 | $3.12M | 0.45% |
| Ameriprise Financial Inc | 500,000 | $2.17M | 0.00% |
| Atika Capital Management LLC | 276,000 | $1.20M | 0.10% |
| Marshall Wace, LLP | 267,200 | $1.16M | 0.00% |
| Bridgeway Capital Management, LLC | 117,995 | $510.9K | 0.01% |
| DLD Asset Management, LP | 100,000 | $433.0K | 0.06% |
| Citadel Advisors LLC | 80,528 | $348.7K | 0.00% |
| Qube Research & Technologies Ltd | 31,938 | $138.3K | 0.00% |
| Squarepoint Ops LLC | 25,121 | $108.8K | 0.00% |
| Forefront Wealth Partners, LLC | 21,518 | $93.2K | 0.02% |
| Scientech Research LLC | 10,369 | $44.9K | 0.02% |
| Clear Street Group Inc. | 1,681 | $7.28K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $4.33K | 0.00% |
| SRS Capital Advisors, Inc. | 36 | $155 | 0.00% |
| Sunbelt Securities, Inc. | 16 | $69 | 0.00% |
| Optiver Holding B.V. | 16 | $69 | 0.00% |
Sold out (14)
Institutions that held Zura Bio Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Charles Schwab Investment Management Inc | 169,180 | $177.6K |
| Y-Intercept (Hong Kong) Ltd | 107,881 | $113.3K |
| Jain Global LLC | 48,750 | $51.2K |
| HRT Financial LP | 32,195 | $33.0K |
| Catalyst Funds Management Pty Ltd | 23,300 | $24.5K |
| Rangeley Capital, LLC | 21,000 | $22.1K |
| Quadrature Capital Ltd | 15,158 | $15.8K |
| CIBC World Markets Inc. | 15,000 | $15.8K |
| Ieq Capital, LLC | 13,841 | $14.5K |
| Ground Swell Capital, LLC | 13,308 | $14.0K |
| R Squared Ltd | 10,201 | $10.7K |
| Point72 (DIFC) Ltd | 601 | $631 |
| Wells Fargo & Company | 385 | $404 |
| Clearstead Advisors, LLC | 239 | $251 |
Not filed for Q3 2025 yet (1)
Institutions that held Zura Bio Ltd at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 1,681 | $1.76K |